The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!
Gastric acid is believed to be an important etiological factor in the pathogenesis of Barrett's esophagus. Pulsatile acid exposure increases cell proliferation in ex vivo Barrrett's tissue and normalization of esophageal pH reverses this. Proton pump inhibitors (PPIs) are the mainstay of t...
Үндсэн зохиолчид: | Leedham, S, Jankowski, J |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2007
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
-н: Omran eAlsalahi, зэрэг
Хэвлэсэн: (2015-01-01) -
Barrett’s Esophagus: Is It All That Bad?
-н: GNJ Tytgat
Хэвлэсэн: (1999-01-01) -
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
-н: Harry Snady
Хэвлэсэн: (2023-12-01) -
Mapping clonality in individual glands in human Barrett's esophagus
-н: Leedham, S, зэрэг
Хэвлэсэн: (2007) -
Gingers and Their Purified Components as Cancer Chemopreventative Agents
-н: John F. Lechner, зэрэг
Хэвлэсэн: (2019-08-01)